Agency
Mountain Communities Healthcare District
Mountain Communities Healthcare District was paid $4.45M by Medicaid between Jan 2018 and Nov 2024, across 82 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 34% of everything it billed.
33Billing provider infoMOUNTAIN COMMUNITIES HEALTHCARE DISTRICT
WEAVERVILLE, CA 96093
WEAVERVILLE, CA 96093
33aNPI1750462271assigned 10/18/2006
33bProvider typeHome Health Agency
28Total paid$4.45M
24GClaims80,182
24DCodes billed82
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Home Health Agency providers in California
Rank by total paid#111 of 1,072
Median peer was paid$9K
This provider vs. median477×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,841 | $295K | |
| 2019 | 9,234 | $398K | |
| 2020 | 8,350 | $490K | |
| 2021 | 10,776 | $656K | |
| 2022 | 14,478 | $974K | |
| 2023 | 14,379 | $895K | |
| 2024incomplete | 13,124 | $739K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 34% | 8,360 | 7,430 | $1.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 11,761 | 10,463 | $948K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.9% | 1,948 | 1,770 | $219K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.6% | 1,160 | 1,079 | $205K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.5% | 2,320 | 917 | $199K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 1,577 | 618 | $127K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.8% | 1,261 | 501 | $123K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 3,897 | 3,769 | $118K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 1,245 | 1,164 | $94K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 1.9% | 577 | 500 | $84K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 983 | 934 | $79K |
| 80053 | Comprehensive metabolic panel | 1.6% | 7,198 | 6,644 | $73K |
70 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 693 | $61K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 219 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 6,530 | $44K |
| 97750 | <1% | 299 | $40K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,442 | $39K |
| 86769 | <1% | 889 | $37K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 757 | $36K |
| A0425 | Ground mileage, per statute mile | <1% | 746 | $28K |
| 80061 | Lipid panel | <1% | 2,006 | $27K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 198 | $20K |
| J3490 | Unclassified drugs | <1% | 2,723 | $19K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 96 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 443 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 204 | $16K |
| Q3014 | Telehealth originating site facility fee | <1% | 1,672 | $15K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,125 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,520 | $14K |
| 81001 | <1% | 2,559 | $13K | |
| 99284 | Emergency room visit (serious) | <1% | 167 | $13K |
| Z7502 | <1% | 324 | $13K | |
| 96367 | <1% | 141 | $12K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 864 | $9K |
| 85027 | <1% | 1,070 | $8K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 196 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 15 | $7K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 29 | $7K |
| 83690 | <1% | 991 | $6K | |
| 84439 | <1% | 632 | $6K | |
| 80305 | <1% | 415 | $6K | |
| 83605 | <1% | 552 | $5K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 516 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 142 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 141 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 592 | $4K |
| 84484 | <1% | 377 | $3K | |
| 86140 | <1% | 665 | $3K | |
| 85007 | <1% | 1,054 | $3K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 16 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 498 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 204 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 12 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 858 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 54 | $2K |
| 87186 | <1% | 197 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 65 | $1K |
| 83880 | <1% | 39 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 200 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 162 | $1K |
| 85610 | <1% | 217 | $928.21 | |
| 87070 | <1% | 69 | $782.22 | |
| 83721 | <1% | 95 | $780.90 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 423 | $769.25 |
| 81025 | <1% | 229 | $697.73 | |
| 86803 | <1% | 52 | $636.00 | |
| 83718 | <1% | 96 | $634.50 | |
| 73030 | <1% | 14 | $582.83 | |
| 83735 | <1% | 64 | $377.04 | |
| 82465 | <1% | 97 | $367.65 | |
| 87340 | <1% | 38 | $351.08 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $347.06 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 16 | $284.55 |
| 86703 | <1% | 13 | $155.48 | |
| 87040 | <1% | 13 | $152.66 | |
| 85651 | <1% | 57 | $131.38 | |
| 87077 | <1% | 13 | $96.22 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $85.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $50.06 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 12 | $45.77 |
| 85652 | <1% | 12 | $26.40 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 16 | $16.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIMPSON, KELLY (DIRECTOR OF REVENUE CYCLE)